Lacey E - Search Results

1

The estrogenic and antiestrogenic activities of droloxifene in human breast cancers.

Kawamura I, Mizota T, Lacey E, Tanaka Y, Manda T, Shimomura K, Kohsaka M. Kawamura I, et al. Among authors: lacey e. Jpn J Pharmacol. 1993 Sep;63(1):27-34. doi: 10.1254/jjp.63.27. Jpn J Pharmacol. 1993. PMID: 8271528 Free article.

2

The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.

Kawamura I, Lacey E, Mizota T, Tsujimoto S, Nishigaki F, Manda T, Shimomura K. Kawamura I, et al. Among authors: lacey e. Anticancer Res. 1994 Mar-Apr;14(2A):427-31. Anticancer Res. 1994. PMID: 8017842

3

Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.

Kawamura I, Lacey E, Tanaka Y, Nishigaki F, Manda T, Shimomura K. Kawamura I, et al. Among authors: lacey e. Jpn J Cancer Res. 1994 Jun;85(6):639-44. doi: 10.1111/j.1349-7006.1994.tb02407.x. Jpn J Cancer Res. 1994. PMID: 8063618 Free PMC article.

4

A new aromatase inhibitor, FR901537. II. Pharmacological and antitumor effects.

Oohata N, Kawamura I, Lacey E, Nishigaki F, Matsumoto S, Tsujimoto S, Naoe Y, Manda T, Shimomura K. Oohata N, et al. Among authors: lacey e. J Antibiot (Tokyo). 1995 Aug;48(8):763-7. doi: 10.7164/antibiotics.48.763. J Antibiot (Tokyo). 1995. PMID: 7592018 Free article.

5

Mechanism of growth inhibition by calpain inhibitor in MCF-7 cells.

Shiba E, Kim SJ, Kambayashi J, Kawamura I, Lacey E, Manda T, Shimomura K, Taguchi T, Takai S. Shiba E, et al. Among authors: lacey e. Anticancer Res. 1997 May-Jun;17(3C):1919-23. Anticancer Res. 1997. PMID: 9216645

6

Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.

Kawamura I, Morishita R, Tomita N, Lacey E, Aketa M, Tsujimoto S, Manda T, Tomoi M, Kida I, Higaki J, Kaneda Y, Shimomura K, Ogihara T. Kawamura I, et al. Among authors: lacey e. Gene Ther. 1999 Jan;6(1):91-7. doi: 10.1038/sj.gt.3300819. Gene Ther. 1999. PMID: 10341880

7

Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI.

Kawamura I, Lacey E, Inami M, Nishigaki F, Naoe Y, Tsujimoto S, Manda T, Goto T. Kawamura I, et al. Among authors: lacey e. Anticancer Res. 1999 Sep-Oct;19(5B):4091-7. Anticancer Res. 1999. PMID: 10628359

8

Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.

Kawamura I, Lacey E, Yamamoto N, Sakai F, Takeshita S, Inami M, Nishigaki F, Naoe Y, Tsujimoto S, Manda T, Shimomura K, Goto T. Kawamura I, et al. Among authors: lacey e. Anticancer Res. 1999 Sep-Oct;19(5B):4105-11. Anticancer Res. 1999. PMID: 10628361

9

Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.

Tsujimoto S, Kawamura I, Inami M, Lacey E, Nishigaki F, Naoe Y, Manda T, Goto T. Tsujimoto S, et al. Among authors: lacey e. Anticancer Res. 2000 Sep-Oct;20(5A):3111-6. Anticancer Res. 2000. PMID: 11062730

10

FR177391, a new anti-hyperlipidemic agent from Serratia. II. Pharmacological activity of FR177391.

Inami M, Kawamura I, Tsujimoto S, Yasuno T, Lacey E, Hirosumi J, Takakura S, Nishigaki F, Naoe Y, Manda T, Mutoh S. Inami M, et al. Among authors: lacey e. J Antibiot (Tokyo). 2005 Oct;58(10):640-7. doi: 10.1038/ja.2005.88. J Antibiot (Tokyo). 2005. PMID: 16392680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters